Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Universe Pharmaceuticals Inc. (UPC:NASDAQ), powered by AI.
Universe Pharmaceuticals Inc. is currently trading at $2.89. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Universe Pharmaceuticals Inc. on Alpha Lenz.
View Universe Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.
“Universe Pharmaceuticals Inc.'s ROE is -7.2%. Explore profitability and growth together.”
Ask for details →Universe Pharmaceuticals Inc. is a specialized company in the pharmaceutical industry focused on traditional Chinese medicine. The company's primary function is the manufacturing, marketing, and distribution of pharmaceuticals, with a significant portion of its products based on traditional Chinese herbal medicines. Universe Pharmaceuticals leverages ancient Chinese medical practices, integrating them with modern processing technologies to create a range of health and wellness products addressing various consumer needs. Notable features of Universe Pharmaceuticals include its extensive portfolio of over-the-counter medicine, dietary supplements, and skincare products that appeal to both domestic and international markets. With operations rooted in applying and preserving traditional knowledge, the company impacts sectors including healthcare, wellness, and consumer goods. In the context of financial markets, Universe Pharmaceuticals Inc. represents a blend of cultural heritage with contemporary scientific approaches, positioning itself uniquely as a bridge between traditional remedies and modern pharmaceuticals. Its presence in the market reflects growing consumer interest in alternative and holistic healthcare solutions, contributing to the diversification of the pharmaceutical industry.
“Universe Pharmaceuticals Inc.'s ROE is -7.2%. Explore profitability and growth together.”
Ask for details →Universe Pharmaceuticals Inc. (ticker: UPC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 225 employees.
The current price is $2.89 with a P/E ratio of -x and P/B of -x.
ROE is -7.23% and operating margin is -16.33%. Annual revenue is $18M.